Hiroo Uehara

Hiroo Uehara

Auto-generated profile, based on publicly available information

Hiroo Uehara

Department of Cardiovascular Surgery, Teikyo University, Itabashi-ku, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
HUHiroo Uehara
Hiroo Uehara
MUMasateru Uchiyama
Masateru Uchiyama
TITomohiro Imazuru
Tomohiro Imazuru
TSTomoki Shimokawa
Tomoki Shimokawa
The number of patients with chronic limb-threatening ischemia has increased in recent years. Herein, we report a rare case of angioplasty with a bovine pericardial patch in a patient with severe stenosis of the common femoral artery. We report a case of a 73-year-old female with intermittent claudication. Ankle-brachial index (ABI) measurements showed a significant decrease of 0.52 on the left, and angiography revealed total occlusion on the left common femoral artery (CFA). Considering additional skin incisions, postoperative wound infection, and potential graft sampling, endarterectomy of the left CFA and patch angioplasty with the bovine pericardium (XenoSure®) were performed. The operative computed tomography showed no stenosis and the ABI improved from 0.52 to 1.15. Additionally, no stenosis, calcification, or dilatation was observed during the follow-up one year after the operation. Various types of peripheral arterial repair were performed after endarterectomy. Autologous vein grafts and vascular prostheses are frequently used considering the background of each patient. Using bovine pericardium over other devices has several advantages, including no additional skin incisions to obtain the patches, resistance to infection, no oozing from the device itself, less bleeding from the suture site, and ease of hemostasis after the puncture under additional endovascular treatment. This case may be a good implication when deciding which device to use in complicated patients. This case provides valuable insight into successful patch angioplasty after endarterectomy without any complications, highlighting the utility of XenoSure® in the treatment of this disease.

14 November 2025 in General Thoracic and Cardiovascular Surgery Cases
Verified
Journal Article
Open access
PDF file
YIYuto Imaizumi
Yuto Imaizumi
HUHiroo Uehara
Hiroo Uehara
MSManato Saitoh
Manato Saitoh
NONaomi Ozawa
Naomi Ozawa
MOMakoto Ono
Makoto Ono
TSTomoki Shimokawa
Tomoki Shimokawa
Background: Accurately distinguishing between coronary arteriovenous malformations (CAVMs) and fistulas is challenging. We encountered a case of preoperatively undiagnosed CAVM. Case presentation: We report the case of a 45-year-old woman diagnosed with cardiac enlargement during a routine health examination. Transthoracic echocardiography showed normal left ventricular systolic function with an ejection fraction of 68%, normal valve function, and a well-defined mass adjacent to the posterior and inferior cardiac walls of the left ventricle. Transesophageal echocardiography revealed a solid mass with a partial honeycomb structure adjacent to the posterior cardiac wall of the left ventricle. A contrast-enhanced computed tomography (CT) scan revealed a solid mass (115 × 79 × 30 mm) with heterogeneous enhancement adhering to the posterior wall and arterial inflow into the mass. Angiography of the right coronary artery revealed mild contrast agent pooling in the venous phase, suggesting the presence of a nutrient vessel in the mass. Cytological examination and histopathological diagnosis after CT-guided needle biopsy revealed Class III tumor with no malignant findings. Considering the challenges in diagnosis with the current tests and the potential risk of cardiac tamponade caused by repeated biopsies, we adopted a policy that tumorectomy should be performed to elucidate the diagnosis. Additional surgical procedures could then be conducted if the intraoperative diagnosis showed a malignant tumor. Intraoperative findings showed that the mass was firmly adherent to the heart between the inferior and lateral walls of the left ventricle. The intraoperative diagnosis of the tumor showed no malignancy. Planned tumorectomy was performed after careful dissection of tumor adhesion. Part of the left marginal vein of the coronary sinus that could not be dissected from the adhesions was resected. Immunohistochemical studies demonstrated CD31+ vascular endothelium, suggesting that the mass was an arteriovenous malformation. The patient’s postoperative course was uneventful, without any signs of recurrence. Conclusion: This case highlights the difficulty of diagnosing CAVM preoperatively and shows that when tumor imaging is ambiguous, CAVM should be considered and early surgical exploration is crucial.

18 February 2025 in The Heart Surgery Forum
Verified
Journal Article
Open access
PDF file
HUHiroo Uehara
Hiroo Uehara
NONaomi Ozawa
Naomi Ozawa
MUMasateru Uchiyama
Masateru Uchiyama
Tomohiro IwakuraTomohiro Iwakura
Tomohiro Iwakura
TITomohiro Imazuru
Tomohiro Imazuru
TSTomoki Shimokawa
Tomoki Shimokawa
Background: Although sutureless aortic valve replacement is rising in popularity, there are few reports on its use in patients on dialysis. This study aimed to investigate the early and mid-term surgical outcomes of the procedure in these patients. Methods: Twenty-one dialysis (mean age, 77.4 ± 5.2 years) patients with aortic stenosis who underwent aortic valve replacement with sutureless and rapid deployment prostheses between May 2019 and March 2021 were enrolled. We retrospectively reviewed and analyzed the clinical courses of all dialysis patients. Data on patient characteristics, surgical procedures, and postoperative outcomes (survival times and major adverse cardiac and cerebrovascular events) were collected. The mean follow-up duration was 371 days (interquartile range (IQR) 364–399). Results: Two (9.5%) operative deaths occurred within 30 days of surgery. The 1-year survival was 85.7%, and the rates of freedom from cardiac death, myocardial infarction, and stroke were 95.0%, 89.7%, and 95.0%, respectively. 1 year freedom from major adverse cardiac and cerebrovascular events was 67.8%. There was one (5.5%) permanent pacemaker implantation 9 months after surgery. No reoperations were performed for any cause. Three patients had moderate prosthesis-patient mismatch 4–7 days after surgery. Effective orifice area index improved from 0.74 cm2/m2 to 0.87 cm2/m2 in one patient 1 year after surgery. No cases of structural valve deterioration or a paravalvular leak were observed. Conclusions: Sutureless aortic valve replacement in dialysis patients may be a novel treatment strategy with lower early mortality rates comparable to those of conventional treatments, increased freedom from pacemaker implantation, and good valve function.

17 April 2025 in The Heart Surgery Forum
Verified
Journal Article
Open access
PDF file
HUHiroo Uehara
Hiroo Uehara
MUMasateru Uchiyama
Masateru Uchiyama
YMYosuke Mukae
Yosuke Mukae
NONaomi Ozawa
Naomi Ozawa
TITomohiro Imazuru
Tomohiro Imazuru
TSTomoki Shimokawa
Tomoki Shimokawa
Background: Sutureless valves are gaining interest for aortic valve replacement in patients with small annuli; however, their effectiveness compared to traditional valves remains unclear. This study aimed to explore the clinical outcomes and hemodynamic performance of sutureless versus stented valves. Methods: In total, 190 patients underwent aortic valve replacement (AVR) at two hospitals from May 2019 to March 2022; 60 patients underwent AVR with Perceval S sutureless aortic valves S size (P group), and 130 underwent AVR with INSPIRIS RESILIA 19 mm (I-19 group) or 21 mm valves (I-21 group). We retrospectively reviewed and analyzed the patient characteristics and intra- and postoperative outcomes. Results: The mean cardiopulmonary bypass (CPB) and aortic cross-clamp (ACC) times were significantly shorter in the P group than in the I group. There were no significant differences in intensive care unit length of stay, hospitalization, and 30-day mortality. The echocardiographic evaluation showed no significant differences in prosthesis performances between the P group and I-19 group 4–7 days after surgery. However, the performance in the I-21 group significantly differed from that in the P group. At the 1 year follow-up, prosthesis performance in the P group was equivalent to that in the I-21 group. Conclusions: Surgical intervention with S size Perceval S sutureless valves is a safe and effective treatment for patients with a small aortic annulus and demonstrates superior intermediate-term hemodynamic performance.